www.law360.com/cases/57c4ba103b73964e4a000001?article_sidebar=1

Apr 30, 2018 ... Parties, docket activity and news coverage of federal case LYONS et al v. BRISTOL-MYERS SQUIBB COMPANY et al, case number ...

www.law360.com/cases/58e6506f2a2edd2f07000001

Oct 18, 2018 ... Parties, docket activity and news coverage of federal case Bristol-Myers Squibb Company et al v. Mylan Pharmaceuticals Inc., case number ...

law.justia.com/cases/federal/district-courts/new-york/nysdce/1:2016cv05668/460419/67

Utts et al v. Bristol-Myers Squibb Company et al, No. 1:2016cv05668 - Document 67 (S.D.N.Y. 2017) case opinion from the Southern District of New York US ...

caselaw.findlaw.com/us-6th-circuit/1878276.html

BRISTOL-MYERS SQUIBB COMPANY; Otsuka America Pharmaceutical, Inc., Defendants-Appellees. ..... Bell Atlantic Corp., et al. v. Twombly, 550 U.S. 544, 555, ...

www.bms.com/researchers-and-partners/our-r-and-d-team/research-publications.html

All-Cause, Stroke/Systemic Embolism-, and Major Bleeding-Related Health-Care ..... Outcomes at 7 years post-transplant in black vs nonblack kidney transplant recipients ...... Bethesda (MD): Eli Lilly & Company and the National Center for Advancing ...... in patients with impaired renal function: response to Hellfritzsch et al.

www.oyez.org/cases/2016/16-466

Apr 25, 2017 ... (BMS) is a global pharmaceutical company incorporated in ... to have suffered harm there; all the relevant acts occurred outside of California.